Table 2.
Repeated-dose study: mean (SD; n = 8) basal and pentagastrin-induced volume, H+ secretion rate and pH of gastric aspirate before and after placebo (Days 0 and 14) and before and after the first dose (Day 1) and last dose (Day 7) of 13 doses of netazepide (100 mg) twice daily
| Basal (0–30 min before dosing) | Pentagastrin (60–180 min after dosing) | ||
|---|---|---|---|
| Day | Mean (SD) | Mean (SD) | |
| Volume (ml min−1) | 0 | 2.4 (1.7) | 3.8 (1.3) |
| 1 | 1.3 (0.7) | 0.8 (0.5)** | |
| 7 | 1.0 (0.5) | 1.3 (0.5)** | |
| 14 | 1.6 (1.2) | 3.2 (0.8) | |
| H+ secretion rate (μmol min−1) | 0 | 105 (73) | 429 (250) |
| 1 | 59 (43) | 30 (53)** | |
| 7 | 41 (38) | 51 (40)** | |
| 14 | 108 (142) | 405 (119) | |
| pH | 0 | 2.0 (1.3) | 1.4 (0.5) |
| 1 | 1.9 (0.5) | 4.3 (2.1)** | |
| 7 | 2.2 (1.2) | 1.9 (0.4) | |
| 14 | 2.0 (1.0) | 1.3 (0.4) |
Asterisks show significant difference (**P < 0.001) from Day 0 by ANCOVA, with subject- and session-specific basal value as covariate.